loading page

Detection of the SARS-CoV-2 in different biologic specimens from positive patients with COVID-19, in Northern Italy
  • +3
  • Fausto Baldanti,
  • Federica Novazzi,
  • Irene Cassaniti,
  • Antonio Piralla,
  • Antonio Di Sabatino,
  • Raffaele Bruno
Fausto Baldanti
University of Pavia
Author Profile
Federica Novazzi
Fondazione IRCCS Policlinico San Matteo
Author Profile
Irene Cassaniti
Fondazione IRCCS Policlinico San Matteo
Author Profile
Antonio Piralla
Fondazione IRCCS Policlinico San Matteo
Author Profile
Antonio Di Sabatino
University of Pavia
Author Profile
Raffaele Bruno
Fondazione IRCCS Policlinico San Matteo
Author Profile

Abstract

Coronavirus disease 2019 (COVID-19)diagnosis is based on molecular detection of SARS-CoV-2 in respiratory samples such as nasal swab (NS). However, the evidence that NS in patients with pneumonia were sometimes negative raise the attention to collect other clinical specimens. SARS-CoV-2 was shown in 10.3%rectal swabs (RS), 7.7% plasma,1% urine, 0% feces from 143NS positive patients. Potential infection by fluids different from respiratory secretion is possible but unlikely.

Peer review status:ACCEPTED

11 Aug 2020Submitted to Pediatric Allergy and Immunology
12 Aug 2020Editorial Decision: Accept